Quest Diagnostics shares are trading higher after the company reported a Q1 earnings beat and raised its 2024 guidance.
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics shares surged following a Q1 earnings beat and an upward revision of its 2024 guidance.

April 23, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Quest Diagnostics reported higher than expected Q1 earnings and raised its 2024 financial outlook.
Earnings beats typically lead to positive investor sentiment and can cause a stock's price to rise. The upward revision of future guidance further strengthens investor confidence in the company's growth prospects, likely leading to a short-term positive impact on DGX's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100